MECOM Function is Critical for AR-Driven Treatment-Resistant Prostate Cancer. Gulla S, Sharma T, Gardner E, Li C, et al. Cancer Res 2026 Jan 13. doi: 10.1158/0008-5472.CAN-25-1720.

Read + Share

Amedeo Smart

Independent Medical Education

Gulla S, Sharma T, Gardner E, Li C, et al. MECOM Function is Critical for AR-Driven Treatment-Resistant Prostate Cancer. Cancer Res 2026 Jan 13. doi: 10.1158/0008-5472.CAN-25-1720.
PMID: 41529070